Carlsmed, Inc. (CARL) received rating reaffirmations from three firms on November 11, 2026. Three bullish, zero neutral, zero bearish. No firm changed its rating.
| Firm | Rating | Tier |
|---|---|---|
| BTIG | Buy | bullish |
| Needham | Buy | bullish |
| Truist Securities | Buy | bullish |
Among three firms active over the past 90 days, three hold a bullish rating. Seven analysts set consensus price targets as of November 6, 2026, with a mean of $19.58, a median of $18.36 and a range of $17.17 to $24.15.
For Q4 FY2026, analysts expect EPS of -$0.39 and revenue of $22.87 million. The next earnings report is scheduled for February 24, 2027.
